Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Jeena Sikho Lifecare operates in Ayurvedic healthcare, running a chain of Ayurveda-based hospitals/clinics and selling Ayurvedic medicines and wellness products associated with the Shuddhi brand. Revenue is driven by patient services at its treatment centres and sales of its proprietary Ayurvedic formulations. It listed on the SME platform before migrating to the main board.
Jeena Sikho Lifecare Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Jeena Sikho Lifecare Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 1.01 crore to 12.43 crore in FY26, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY26 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY22 |
|---|---|---|---|
| EPS (basic, ₹) | 17.84 | — | 11.11 |
| Book value / share (₹) | 37.57 | — | 36.08 |
| Return on equity | 47.5% | — | 30.8% |
| Return on capital employed | 53.0% | — | 39.2% |
| Operating margin | 37.6% | — | 10.1% |
| Net margin | 27.7% | — | 7.6% |
| EBITDA | ₹349 Cr | — | ₹18 Cr |
| Free cash flow | ₹220 Cr | — | ₹-1 Cr |
| Total debt | ₹0 Cr | — | ₹7 Cr |
| Debt to equity | 0.00 | — | 0.20 |
| Interest coverage | 23.5 | — | 12.9 |
| Current ratio | 3.25 | — | 0.90 |
| Shares outstanding | 12,43,00,500 | — | 1,01,11,200 |
Open the full income statement, balance sheet and cash flow for JSLL →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.